NZ503484A - Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives - Google Patents
Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivativesInfo
- Publication number
- NZ503484A NZ503484A NZ503484A NZ50348498A NZ503484A NZ 503484 A NZ503484 A NZ 503484A NZ 503484 A NZ503484 A NZ 503484A NZ 50348498 A NZ50348498 A NZ 50348498A NZ 503484 A NZ503484 A NZ 503484A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- benzothieno
- alkyl
- methylpiperazin
- methyl
- Prior art date
Links
- -1 thieno[2 Chemical compound 0.000 title claims abstract description 202
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 title claims description 105
- 229940049706 benzodiazepine Drugs 0.000 title claims description 105
- ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical compound O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 title claims description 22
- 125000005605 benzo group Chemical group 0.000 title description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 295
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 147
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 132
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 93
- 239000001257 hydrogen Substances 0.000 claims abstract description 93
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 83
- 125000001424 substituent group Chemical group 0.000 claims abstract description 76
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims abstract description 74
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 63
- 150000002367 halogens Chemical class 0.000 claims abstract description 63
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 56
- 229930192474 thiophene Natural products 0.000 claims abstract description 54
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims abstract description 46
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 44
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract description 43
- 125000004103 aminoalkyl group Chemical group 0.000 claims abstract description 38
- 150000001350 alkyl halides Chemical class 0.000 claims abstract description 36
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 33
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims abstract description 31
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 31
- 125000002252 acyl group Chemical group 0.000 claims abstract description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 23
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 18
- 201000000980 schizophrenia Diseases 0.000 claims abstract description 17
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 17
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 15
- 125000004442 acylamino group Chemical group 0.000 claims abstract description 13
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract description 12
- 229910052701 rubidium Inorganic materials 0.000 claims abstract description 12
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims abstract description 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 11
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims abstract description 10
- 125000005041 acyloxyalkyl group Chemical group 0.000 claims abstract description 10
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 10
- 239000008177 pharmaceutical agent Substances 0.000 claims abstract description 8
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 7
- 208000028683 bipolar I disease Diseases 0.000 claims abstract description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 126
- 238000006243 chemical reaction Methods 0.000 claims description 89
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical compound N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 claims description 62
- BDINXVWBBJGVFA-UHFFFAOYSA-N 5h-1,2-benzoxazepin-4-one Chemical compound O1N=CC(=O)CC2=CC=CC=C21 BDINXVWBBJGVFA-UHFFFAOYSA-N 0.000 claims description 58
- 150000003839 salts Chemical class 0.000 claims description 43
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 41
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 37
- 239000011541 reaction mixture Substances 0.000 claims description 36
- 125000004432 carbon atom Chemical group C* 0.000 claims description 34
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 34
- 239000000164 antipsychotic agent Substances 0.000 claims description 19
- 208000024891 symptom Diseases 0.000 claims description 18
- FCEHBMOGCRZNNI-UHFFFAOYSA-N thianaphthalene Natural products C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 15
- 229960004170 clozapine Drugs 0.000 claims description 11
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 150000004677 hydrates Chemical class 0.000 claims description 11
- 239000000543 intermediate Substances 0.000 claims description 10
- 201000010000 Agranulocytosis Diseases 0.000 claims description 9
- 206010029350 Neurotoxicity Diseases 0.000 claims description 5
- 206010044221 Toxic encephalopathy Diseases 0.000 claims description 5
- 231100000228 neurotoxicity Toxicity 0.000 claims description 5
- 230000007135 neurotoxicity Effects 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 239000007806 chemical reaction intermediate Substances 0.000 claims description 4
- WZJZHBDLEUPLSZ-UHFFFAOYSA-N 8-fluoro-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2OC2=C1C=C(C)S2 WZJZHBDLEUPLSZ-UHFFFAOYSA-N 0.000 claims description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 208000019430 Motor disease Diseases 0.000 claims description 3
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 3
- QLTXKCWMEZIHBJ-PJGJYSAQSA-N dizocilpine maleate Chemical compound OC(=O)\C=C/C(O)=O.C12=CC=CC=C2[C@]2(C)C3=CC=CC=C3C[C@H]1N2 QLTXKCWMEZIHBJ-PJGJYSAQSA-N 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- XNMFPRJGFYVVDH-UHFFFAOYSA-N 2,3-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C(C)=C(C)S2 XNMFPRJGFYVVDH-UHFFFAOYSA-N 0.000 claims description 2
- ZIWSZVGZEHWZDJ-UHFFFAOYSA-N 2-ethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(CC)=C2 ZIWSZVGZEHWZDJ-UHFFFAOYSA-N 0.000 claims description 2
- HNUUKNDCZZFORM-UHFFFAOYSA-N 2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C)=C2 HNUUKNDCZZFORM-UHFFFAOYSA-N 0.000 claims description 2
- DCNNKEJCLNYKAO-UHFFFAOYSA-N 8-methoxy-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1=2C=C(C)SC=2OC2=CC(OC)=CC=C2N=C1N1CCN(C)CC1 DCNNKEJCLNYKAO-UHFFFAOYSA-N 0.000 claims description 2
- 208000009132 Catalepsy Diseases 0.000 claims description 2
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 241000700159 Rattus Species 0.000 claims description 2
- 206010047853 Waxy flexibility Diseases 0.000 claims description 2
- 230000003354 anti-apomorphinic effect Effects 0.000 claims description 2
- 230000001143 conditioned effect Effects 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims description 2
- 229960001252 methamphetamine Drugs 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 238000000804 electron spin resonance spectroscopy Methods 0.000 claims 2
- 230000003647 oxidation Effects 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- DPACDUNWMZUWTJ-UHFFFAOYSA-N 2,6-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=C(C)C=CC=C2OC2=C1C=C(C)S2 DPACDUNWMZUWTJ-UHFFFAOYSA-N 0.000 claims 1
- IEIVTDQRSPHBLU-UHFFFAOYSA-N 2-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC(C)=CC=C1S2 IEIVTDQRSPHBLU-UHFFFAOYSA-N 0.000 claims 1
- NIWYIVLXQJBRNR-UHFFFAOYSA-N 8-methoxy-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(OC)=CC=C2NC(=O)C2=C1SC(C)=C2 NIWYIVLXQJBRNR-UHFFFAOYSA-N 0.000 claims 1
- RVRXXWFHKUVBMP-UHFFFAOYSA-N 8-methyl-11h-[1]benzothiolo[2,3-b][1,5]benzoxazepin-12-one Chemical compound O1C2=CC(C)=CC=C2NC(=O)C2=C1SC1=CC=CC=C21 RVRXXWFHKUVBMP-UHFFFAOYSA-N 0.000 claims 1
- 102000003992 Peroxidases Human genes 0.000 claims 1
- 230000008485 antagonism Effects 0.000 claims 1
- 229940005529 antipsychotics Drugs 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 108040007629 peroxidase activity proteins Proteins 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 238
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 226
- 239000002904 solvent Substances 0.000 description 195
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 190
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 178
- 239000007858 starting material Substances 0.000 description 152
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 150
- 230000015572 biosynthetic process Effects 0.000 description 150
- 238000003786 synthesis reaction Methods 0.000 description 150
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 132
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 117
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 95
- 230000002829 reductive effect Effects 0.000 description 86
- 239000013078 crystal Substances 0.000 description 80
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 80
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 78
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 75
- 238000002844 melting Methods 0.000 description 72
- 230000008018 melting Effects 0.000 description 72
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 72
- 239000000243 solution Substances 0.000 description 70
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 69
- 238000005160 1H NMR spectroscopy Methods 0.000 description 64
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 63
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 63
- 239000012046 mixed solvent Substances 0.000 description 63
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 61
- 230000002411 adverse Effects 0.000 description 60
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 57
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 55
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 54
- 238000000034 method Methods 0.000 description 52
- 238000001914 filtration Methods 0.000 description 51
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 50
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 50
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 48
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 48
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 41
- 101150041968 CDC13 gene Proteins 0.000 description 40
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 40
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 40
- 229910000027 potassium carbonate Inorganic materials 0.000 description 40
- 239000008096 xylene Substances 0.000 description 40
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 39
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 38
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 33
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 32
- 238000010438 heat treatment Methods 0.000 description 32
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 30
- 238000010992 reflux Methods 0.000 description 30
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 28
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 28
- 238000010189 synthetic method Methods 0.000 description 28
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 25
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 25
- 238000000354 decomposition reaction Methods 0.000 description 25
- 150000002431 hydrogen Chemical class 0.000 description 25
- 239000011976 maleic acid Substances 0.000 description 25
- 238000010898 silica gel chromatography Methods 0.000 description 25
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 25
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 25
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 24
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 22
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 22
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 22
- 229910052938 sodium sulfate Inorganic materials 0.000 description 22
- 235000011152 sodium sulphate Nutrition 0.000 description 22
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 21
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 18
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 16
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
- 150000007529 inorganic bases Chemical class 0.000 description 16
- 229910000029 sodium carbonate Inorganic materials 0.000 description 16
- 239000012312 sodium hydride Substances 0.000 description 16
- 229910000104 sodium hydride Inorganic materials 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- XNASJEQIJMDBQN-UHFFFAOYSA-N ethyl 2-amino-1-benzothiophene-3-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 XNASJEQIJMDBQN-UHFFFAOYSA-N 0.000 description 15
- 150000007530 organic bases Chemical class 0.000 description 15
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 15
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 14
- 238000001816 cooling Methods 0.000 description 14
- YNVOMSDITJMNET-UHFFFAOYSA-M thiophene-3-carboxylate Chemical compound [O-]C(=O)C=1C=CSC=1 YNVOMSDITJMNET-UHFFFAOYSA-M 0.000 description 14
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 13
- DZMYKWBJZZTINV-UHFFFAOYSA-N 2-bromo-5-methylthiophene-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=C(Br)S1 DZMYKWBJZZTINV-UHFFFAOYSA-N 0.000 description 13
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 13
- 239000012044 organic layer Substances 0.000 description 13
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 13
- 235000011150 stannous chloride Nutrition 0.000 description 13
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 13
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 150000003613 toluenes Chemical class 0.000 description 12
- 150000004683 dihydrates Chemical class 0.000 description 11
- 235000019341 magnesium sulphate Nutrition 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 229910052708 sodium Inorganic materials 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 230000009471 action Effects 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 10
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 235000013922 glutamic acid Nutrition 0.000 description 9
- 239000004220 glutamic acid Substances 0.000 description 9
- 239000005457 ice water Substances 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- RJXOVESYJFXCGI-UHFFFAOYSA-N 2,4-difluoro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1F RJXOVESYJFXCGI-UHFFFAOYSA-N 0.000 description 8
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 8
- 239000001530 fumaric acid Substances 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 150000007522 mineralic acids Chemical class 0.000 description 8
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 8
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 8
- DHBXNPKRAUYBTH-UHFFFAOYSA-N 1,1-ethanedithiol Chemical compound CC(S)S DHBXNPKRAUYBTH-UHFFFAOYSA-N 0.000 description 7
- PWKNBLFSJAVFAB-UHFFFAOYSA-N 1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1F PWKNBLFSJAVFAB-UHFFFAOYSA-N 0.000 description 7
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 210000000653 nervous system Anatomy 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- FHGWEHGZBUBQKL-UHFFFAOYSA-N 1,2-benzothiazepine Chemical compound S1N=CC=CC2=CC=CC=C12 FHGWEHGZBUBQKL-UHFFFAOYSA-N 0.000 description 6
- MRHCHEZVUNHHBL-UHFFFAOYSA-N 2-bromo-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid Chemical compound C1CCCC2=C1SC(Br)=C2C(=O)O MRHCHEZVUNHHBL-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 102000015554 Dopamine receptor Human genes 0.000 description 6
- 108050004812 Dopamine receptor Proteins 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- WDCDAAMJNUHOIY-UHFFFAOYSA-N ethyl acetate;2-propan-2-yloxypropane Chemical compound CCOC(C)=O.CC(C)OC(C)C WDCDAAMJNUHOIY-UHFFFAOYSA-N 0.000 description 6
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 229910017604 nitric acid Inorganic materials 0.000 description 5
- 229960005017 olanzapine Drugs 0.000 description 5
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 description 4
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 239000003693 atypical antipsychotic agent Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012320 chlorinating reagent Substances 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 229960003638 dopamine Drugs 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 3
- WNXWDETZPAYBPB-UHFFFAOYSA-N 2-amino-1-benzothiophene-3-carbonitrile Chemical compound C1=CC=C2C(C#N)=C(N)SC2=C1 WNXWDETZPAYBPB-UHFFFAOYSA-N 0.000 description 3
- YFCBPFNUJGLSOW-UHFFFAOYSA-N 2-amino-6-fluoro-1-benzothiophene-3-carbonitrile Chemical compound FC1=CC=C2C(C#N)=C(N)SC2=C1 YFCBPFNUJGLSOW-UHFFFAOYSA-N 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 229940127236 atypical antipsychotics Drugs 0.000 description 3
- 150000001540 azides Chemical class 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- QMOWSXPVRZVEQZ-UHFFFAOYSA-N ethyl 2-(2-amino-4,5-dichloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Cl)=C(Cl)C=C1N QMOWSXPVRZVEQZ-UHFFFAOYSA-N 0.000 description 3
- WXSSKYJARAAISM-UHFFFAOYSA-N ethyl 2-(2-amino-5-chloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Cl)=CC=C1N WXSSKYJARAAISM-UHFFFAOYSA-N 0.000 description 3
- AXMZTUJGKOVBTD-UHFFFAOYSA-N ethyl 2-(2-amino-5-fluoroanilino)-6-bromo-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(Br)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1N AXMZTUJGKOVBTD-UHFFFAOYSA-N 0.000 description 3
- GNQDTAQXURPNNS-UHFFFAOYSA-N ethyl 2-(2-aminoanilino)-6-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1N GNQDTAQXURPNNS-UHFFFAOYSA-N 0.000 description 3
- MIGLNVQWMJSSTR-UHFFFAOYSA-N ethyl 2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1[N+]([O-])=O MIGLNVQWMJSSTR-UHFFFAOYSA-N 0.000 description 3
- QAFXCLVKCVHMPV-UHFFFAOYSA-N ethyl 2-(5-chloro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Cl)=CC=C1[N+]([O-])=O QAFXCLVKCVHMPV-UHFFFAOYSA-N 0.000 description 3
- ZQOBNIAGPAHJPX-UHFFFAOYSA-N ethyl 2-[2-amino-4-(trifluoromethyl)anilino]-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(C(F)(F)F)C=C1N ZQOBNIAGPAHJPX-UHFFFAOYSA-N 0.000 description 3
- RVJAKQJEJNVOCC-UHFFFAOYSA-N ethyl 2-amino-6-methyl-1-benzothiophene-3-carboxylate Chemical compound CC1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 RVJAKQJEJNVOCC-UHFFFAOYSA-N 0.000 description 3
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 3
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 3
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- PPOJWDMKBVWXMU-UHFFFAOYSA-N methyl 2-amino-5-methyl-1-benzothiophene-3-carboxylate Chemical compound C1=C(C)C=C2C(C(=O)OC)=C(N)SC2=C1 PPOJWDMKBVWXMU-UHFFFAOYSA-N 0.000 description 3
- 230000002887 neurotoxic effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000012453 solvate Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- ROJNMGYMBLNTPK-UHFFFAOYSA-N 1,2,4-trifluoro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=C(F)C=C1F ROJNMGYMBLNTPK-UHFFFAOYSA-N 0.000 description 2
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 2
- XNJAYQHWXYJBBD-UHFFFAOYSA-N 1,4-difluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=CC=C1F XNJAYQHWXYJBBD-UHFFFAOYSA-N 0.000 description 2
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 2
- CMLNKSAEGMMNFS-UHFFFAOYSA-N 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carbonitrile Chemical compound NC1=CC=C(F)C=C1NC1=C(C#N)C2=CC=CC=C2S1 CMLNKSAEGMMNFS-UHFFFAOYSA-N 0.000 description 2
- KJCRYAYREICHCZ-UHFFFAOYSA-N 2-(4-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC(F)=CC=C1NC1=C(C#N)C2=CC=CC=C2S1 KJCRYAYREICHCZ-UHFFFAOYSA-N 0.000 description 2
- WTEGMBXIKULAJP-UHFFFAOYSA-N 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1NC1=C(C#N)C2=CC=CC=C2S1 WTEGMBXIKULAJP-UHFFFAOYSA-N 0.000 description 2
- LUSKKLJWMBHKEJ-UHFFFAOYSA-N 2-(5-fluoro-2-nitroanilino)-6-methoxy-1-benzothiophene-3-carbonitrile Chemical compound S1C2=CC(OC)=CC=C2C(C#N)=C1NC1=CC(F)=CC=C1[N+]([O-])=O LUSKKLJWMBHKEJ-UHFFFAOYSA-N 0.000 description 2
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 2
- IIDUNAVOCYMUFB-UHFFFAOYSA-N 2-amino-5-fluorophenol Chemical compound NC1=CC=C(F)C=C1O IIDUNAVOCYMUFB-UHFFFAOYSA-N 0.000 description 2
- HCPJEHJGFKWRFM-UHFFFAOYSA-N 2-amino-5-methylphenol Chemical compound CC1=CC=C(N)C(O)=C1 HCPJEHJGFKWRFM-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- VRVRGVPWCUEOGV-UHFFFAOYSA-N 2-aminothiophenol Chemical compound NC1=CC=CC=C1S VRVRGVPWCUEOGV-UHFFFAOYSA-N 0.000 description 2
- YTSXOSPFIWDJGQ-UHFFFAOYSA-N 2-bromo-5-methylthiophene-3-carbonyl chloride Chemical compound CC1=CC(C(Cl)=O)=C(Br)S1 YTSXOSPFIWDJGQ-UHFFFAOYSA-N 0.000 description 2
- UHBVOYZUTBXFEC-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-3-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=C(C)C=CC=2)O)=C1Br UHBVOYZUTBXFEC-UHFFFAOYSA-N 0.000 description 2
- AOHGCLLPABQAKW-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methoxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound OC1=CC(OC)=CC=C1NC(=O)C1=C(Br)SC(C)=C1 AOHGCLLPABQAKW-UHFFFAOYSA-N 0.000 description 2
- XOUQLULTOLZSLZ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound OC1=CC(C)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 XOUQLULTOLZSLZ-UHFFFAOYSA-N 0.000 description 2
- IIRJIHAEWMNCAT-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-nitrophenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(=CC=2)[N+]([O-])=O)O)=C1Br IIRJIHAEWMNCAT-UHFFFAOYSA-N 0.000 description 2
- UBKLVDSMEYZYLQ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-5-nitrophenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=C(C=2)[N+]([O-])=O)O)=C1Br UBKLVDSMEYZYLQ-UHFFFAOYSA-N 0.000 description 2
- NBIZOERPLUNAFF-UHFFFAOYSA-N 2-bromo-n-(2-hydroxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound OC1=CC=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 NBIZOERPLUNAFF-UHFFFAOYSA-N 0.000 description 2
- KSMKBOCNBHLLOW-UHFFFAOYSA-N 2-bromo-n-(2-hydroxyphenyl)-4,5-dimethylthiophene-3-carboxamide Chemical compound CC1=C(C)SC(Br)=C1C(=O)NC1=CC=CC=C1O KSMKBOCNBHLLOW-UHFFFAOYSA-N 0.000 description 2
- YYLPJDGPHCQMNZ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=CC=2)O)=C1Br YYLPJDGPHCQMNZ-UHFFFAOYSA-N 0.000 description 2
- STIIWLOSNDCLKU-UHFFFAOYSA-N 2-bromo-n-(2-hydroxyphenyl)thiophene-3-carboxamide Chemical compound OC1=CC=CC=C1NC(=O)C1=C(Br)SC=C1 STIIWLOSNDCLKU-UHFFFAOYSA-N 0.000 description 2
- FHEQLIGENFOJQX-UHFFFAOYSA-N 2-bromo-n-(2-sulfanylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound SC1=CC=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 FHEQLIGENFOJQX-UHFFFAOYSA-N 0.000 description 2
- KDCUQZOUZUEQJN-UHFFFAOYSA-N 2-bromo-n-(4-chloro-2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(Cl)=CC=2)O)=C1Br KDCUQZOUZUEQJN-UHFFFAOYSA-N 0.000 description 2
- XBKRCAMXZKWVRS-UHFFFAOYSA-N 2-bromo-n-(4-fluoro-2-hydroxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound OC1=CC(F)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 XBKRCAMXZKWVRS-UHFFFAOYSA-N 0.000 description 2
- PDIYHBOFLLRICO-UHFFFAOYSA-N 2-bromo-n-(4-fluoro-2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(F)=CC=2)O)=C1Br PDIYHBOFLLRICO-UHFFFAOYSA-N 0.000 description 2
- LFSDCRTUYZAWPX-UHFFFAOYSA-N 2-bromo-n-(4-methyl-2-sulfanylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound SC1=CC(C)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 LFSDCRTUYZAWPX-UHFFFAOYSA-N 0.000 description 2
- WZMOWQCNPFDWPA-UHFFFAOYSA-N 2-fluoro-4-methyl-1-nitrobenzene Chemical compound CC1=CC=C([N+]([O-])=O)C(F)=C1 WZMOWQCNPFDWPA-UHFFFAOYSA-N 0.000 description 2
- UJBOOUHRTQVGRU-UHFFFAOYSA-N 3-methylcyclohexan-1-one Chemical compound CC1CCCC(=O)C1 UJBOOUHRTQVGRU-UHFFFAOYSA-N 0.000 description 2
- OUBUUZCKCDMLNY-UHFFFAOYSA-N 4-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound N#CC=1C=2C(C)=CC=CC=2SC=1NC1=CC=CC=C1[N+]([O-])=O OUBUUZCKCDMLNY-UHFFFAOYSA-N 0.000 description 2
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 description 2
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 description 2
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 description 2
- VWFUBWYVCWTDJA-UHFFFAOYSA-N 6-chloro-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=CC=C1NC1=C(C#N)C2=CC=C(Cl)C=C2S1 VWFUBWYVCWTDJA-UHFFFAOYSA-N 0.000 description 2
- AZMBEEBVOTUYAD-UHFFFAOYSA-N 6-fluoro-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=CC=C1NC1=C(C#N)C2=CC=C(F)C=C2S1 AZMBEEBVOTUYAD-UHFFFAOYSA-N 0.000 description 2
- NWACFUIXVJSSTQ-UHFFFAOYSA-N 6-fluoro-2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1NC1=C(C#N)C2=CC=C(F)C=C2S1 NWACFUIXVJSSTQ-UHFFFAOYSA-N 0.000 description 2
- PVZLBXQZTADBMA-UHFFFAOYSA-N 6-fluoro-2-(5-methyl-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound CC1=CC=C([N+]([O-])=O)C(NC2=C(C3=CC=C(F)C=C3S2)C#N)=C1 PVZLBXQZTADBMA-UHFFFAOYSA-N 0.000 description 2
- VHTDOHQYIYRUTJ-UHFFFAOYSA-N 8-chloro-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(Cl)=CC=C2NC(=O)C2=C1SC(C)=C2 VHTDOHQYIYRUTJ-UHFFFAOYSA-N 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000000561 anti-psychotic effect Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940045803 cuprous chloride Drugs 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 2
- VVEUUAMZAXOKHU-UHFFFAOYSA-N ethyl 2-(2-amino-3,5-difluoroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC(F)=C1N VVEUUAMZAXOKHU-UHFFFAOYSA-N 0.000 description 2
- ZUGGKNNHJQTQNS-UHFFFAOYSA-N ethyl 2-(2-amino-4,5-difluoroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=C(F)C=C1N ZUGGKNNHJQTQNS-UHFFFAOYSA-N 0.000 description 2
- ORIQFCSPEBPYJB-UHFFFAOYSA-N ethyl 2-(2-amino-4-fluoroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(F)C=C1N ORIQFCSPEBPYJB-UHFFFAOYSA-N 0.000 description 2
- BADPAWFYMQITIL-UHFFFAOYSA-N ethyl 2-(2-amino-4-methoxyanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(OC)C=C1N BADPAWFYMQITIL-UHFFFAOYSA-N 0.000 description 2
- IMCDWXIAMGKOSP-UHFFFAOYSA-N ethyl 2-(2-amino-4-methylanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(C)C=C1N IMCDWXIAMGKOSP-UHFFFAOYSA-N 0.000 description 2
- SFPIUDQLQRZBQN-UHFFFAOYSA-N ethyl 2-(2-amino-5-bromoanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Br)=CC=C1N SFPIUDQLQRZBQN-UHFFFAOYSA-N 0.000 description 2
- SKDKWKMPDKFYNZ-UHFFFAOYSA-N ethyl 2-(2-amino-5-fluoroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1N SKDKWKMPDKFYNZ-UHFFFAOYSA-N 0.000 description 2
- KZVBYOOMBMKYEL-UHFFFAOYSA-N ethyl 2-(2-amino-5-methylanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(C)=CC=C1N KZVBYOOMBMKYEL-UHFFFAOYSA-N 0.000 description 2
- CBHIGKFYVWIYNZ-UHFFFAOYSA-N ethyl 2-(2-aminoanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1N CBHIGKFYVWIYNZ-UHFFFAOYSA-N 0.000 description 2
- KVVVVBZDNQHBAZ-UHFFFAOYSA-N ethyl 2-(3,5-difluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC(F)=C1[N+]([O-])=O KVVVVBZDNQHBAZ-UHFFFAOYSA-N 0.000 description 2
- OGMQAKWVDNFXHI-UHFFFAOYSA-N ethyl 2-(4,5-difluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=C(F)C=C1[N+]([O-])=O OGMQAKWVDNFXHI-UHFFFAOYSA-N 0.000 description 2
- KTIPRRPWBNRUSG-UHFFFAOYSA-N ethyl 2-(4-bromo-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(Br)C=C1[N+]([O-])=O KTIPRRPWBNRUSG-UHFFFAOYSA-N 0.000 description 2
- QHFDSLUCHXBBOT-UHFFFAOYSA-N ethyl 2-(4-chloro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(Cl)C=C1[N+]([O-])=O QHFDSLUCHXBBOT-UHFFFAOYSA-N 0.000 description 2
- KJMVRKAVXGYZQF-UHFFFAOYSA-N ethyl 2-(4-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(F)C=C1[N+]([O-])=O KJMVRKAVXGYZQF-UHFFFAOYSA-N 0.000 description 2
- PINYBUWXBMFEKY-UHFFFAOYSA-N ethyl 2-(4-methoxy-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(OC)C=C1[N+]([O-])=O PINYBUWXBMFEKY-UHFFFAOYSA-N 0.000 description 2
- AJKFRJJPYLGNMP-UHFFFAOYSA-N ethyl 2-(5-bromo-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Br)=CC=C1[N+]([O-])=O AJKFRJJPYLGNMP-UHFFFAOYSA-N 0.000 description 2
- SPERSYZLMVWQHC-UHFFFAOYSA-N ethyl 2-(5-fluoro-2-nitroanilino)-6-methoxy-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(OC)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1[N+]([O-])=O SPERSYZLMVWQHC-UHFFFAOYSA-N 0.000 description 2
- ULQZMYNJGQXUTK-UHFFFAOYSA-N ethyl 2-(5-fluoro-2-nitroanilino)-6-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1[N+]([O-])=O ULQZMYNJGQXUTK-UHFFFAOYSA-N 0.000 description 2
- JAJMMVCLXOKJOX-UHFFFAOYSA-N ethyl 2-(6-amino-2,3-dichloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=C(N)C=CC(Cl)=C1Cl JAJMMVCLXOKJOX-UHFFFAOYSA-N 0.000 description 2
- NWTVOYKIAQFEDW-UHFFFAOYSA-N ethyl 2-(n-methyl-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1N(C)C1=CC=CC=C1[N+]([O-])=O NWTVOYKIAQFEDW-UHFFFAOYSA-N 0.000 description 2
- IWVMBAUTNRSMEI-UHFFFAOYSA-N ethyl 2-amino-6-methoxy-1-benzothiophene-3-carboxylate Chemical compound COC1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 IWVMBAUTNRSMEI-UHFFFAOYSA-N 0.000 description 2
- KXOLGQFXAGTKEC-UHFFFAOYSA-N ethyl 6-bromo-2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(Br)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1[N+]([O-])=O KXOLGQFXAGTKEC-UHFFFAOYSA-N 0.000 description 2
- SUUHANOQKIFWRU-UHFFFAOYSA-N ethyl 6-methoxy-2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(OC)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1[N+]([O-])=O SUUHANOQKIFWRU-UHFFFAOYSA-N 0.000 description 2
- LVGPCELNQXKDGG-UHFFFAOYSA-N ethyl 6-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1[N+]([O-])=O LVGPCELNQXKDGG-UHFFFAOYSA-N 0.000 description 2
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003863 metallic catalyst Substances 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- GLEOAGSTXRQFCS-UHFFFAOYSA-N methyl 2-(2-amino-5-fluoroanilino)-5-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=C(C)C=C2C(C(=O)OC)=C1NC1=CC(F)=CC=C1N GLEOAGSTXRQFCS-UHFFFAOYSA-N 0.000 description 2
- PFRZKSQRSJESHT-UHFFFAOYSA-N methyl 2-(2-aminoanilino)-5-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=C(C)C=C2C(C(=O)OC)=C1NC1=CC=CC=C1N PFRZKSQRSJESHT-UHFFFAOYSA-N 0.000 description 2
- HTFSIWRAACXRRH-UHFFFAOYSA-N methyl 2-(5-fluoro-2-nitroanilino)-5-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=C(C)C=C2C(C(=O)OC)=C1NC1=CC(F)=CC=C1[N+]([O-])=O HTFSIWRAACXRRH-UHFFFAOYSA-N 0.000 description 2
- LOHNKDNSGRNHMD-UHFFFAOYSA-N methyl 5-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=C(C)C=C2C(C(=O)OC)=C1NC1=CC=CC=C1[N+]([O-])=O LOHNKDNSGRNHMD-UHFFFAOYSA-N 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- CLURAKRVQIPBCC-UHFFFAOYSA-M sodium;perbromate Chemical compound [Na+].[O-]Br(=O)(=O)=O CLURAKRVQIPBCC-UHFFFAOYSA-M 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- IWJQUKHIWQAEDS-WLHGVMLRSA-N (e)-but-2-enedioic acid;4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound OC(=O)\C=C\C(O)=O.C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C=CS2 IWJQUKHIWQAEDS-WLHGVMLRSA-N 0.000 description 1
- BGKIECJVXXHLDP-UHFFFAOYSA-N 1,2,3-trichloro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(Cl)=C1Cl BGKIECJVXXHLDP-UHFFFAOYSA-N 0.000 description 1
- IBRBMZRLVYKVRF-UHFFFAOYSA-N 1,2,4-trichloro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(Cl)C=C1Cl IBRBMZRLVYKVRF-UHFFFAOYSA-N 0.000 description 1
- PWRFDGYYJWQIAB-UHFFFAOYSA-N 1,3,5-trifluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=C(F)C=C(F)C=C1F PWRFDGYYJWQIAB-UHFFFAOYSA-N 0.000 description 1
- WRGKKASJBOREMB-UHFFFAOYSA-N 1,4-dibromo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC=C1Br WRGKKASJBOREMB-UHFFFAOYSA-N 0.000 description 1
- RZKKOBGFCAHLCZ-UHFFFAOYSA-N 1,4-dichloro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC=C1Cl RZKKOBGFCAHLCZ-UHFFFAOYSA-N 0.000 description 1
- RAVKDBINTWOXDN-UHFFFAOYSA-N 1,5-benzoxazepine Chemical compound O1C=CC=NC2=CC=CC=C12 RAVKDBINTWOXDN-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- UUORGSXWPOMXJJ-UHFFFAOYSA-N 1-[azido(ethyl)phosphoryl]ethane Chemical compound CCP(=O)(CC)N=[N+]=[N-] UUORGSXWPOMXJJ-UHFFFAOYSA-N 0.000 description 1
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 1
- BFCFYVKQTRLZHA-UHFFFAOYSA-N 1-chloro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1Cl BFCFYVKQTRLZHA-UHFFFAOYSA-N 0.000 description 1
- HNZJIWIXRPBFAN-UHFFFAOYSA-N 1-cyclopropylpiperazine Chemical compound C1CC1N1CCNCC1 HNZJIWIXRPBFAN-UHFFFAOYSA-N 0.000 description 1
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 1
- HLDFCCHSOZWKAA-UHFFFAOYSA-N 1-fluoro-2-nitro-4-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1F HLDFCCHSOZWKAA-UHFFFAOYSA-N 0.000 description 1
- ZRIKJXDEJYMBEJ-UHFFFAOYSA-N 1-fluoro-4-methoxy-2-nitrobenzene Chemical compound COC1=CC=C(F)C([N+]([O-])=O)=C1 ZRIKJXDEJYMBEJ-UHFFFAOYSA-N 0.000 description 1
- OORBDHOQLZRIQR-UHFFFAOYSA-N 1-fluoro-4-methyl-2-nitrobenzene Chemical compound CC1=CC=C(F)C([N+]([O-])=O)=C1 OORBDHOQLZRIQR-UHFFFAOYSA-N 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- FXHRAKUEZPSMLJ-UHFFFAOYSA-N 1-methyl-1,4-diazepane Chemical compound CN1CCCNCC1 FXHRAKUEZPSMLJ-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WHKWMTXTYKVFLK-UHFFFAOYSA-N 1-propan-2-ylpiperazine Chemical compound CC(C)N1CCNCC1 WHKWMTXTYKVFLK-UHFFFAOYSA-N 0.000 description 1
- QLEIDMAURCRVCX-UHFFFAOYSA-N 1-propylpiperazine Chemical compound CCCN1CCNCC1 QLEIDMAURCRVCX-UHFFFAOYSA-N 0.000 description 1
- LDBHGFASMHVSDJ-UHFFFAOYSA-N 12-(4-ethylpiperazin-1-yl)-8-fluoro-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(CC)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC=C1S2 LDBHGFASMHVSDJ-UHFFFAOYSA-N 0.000 description 1
- REZDERXFCZZZLU-UHFFFAOYSA-N 2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound O=C1NC2=CC=CC=C2SC2=C1C(CCCC1)=C1S2 REZDERXFCZZZLU-UHFFFAOYSA-N 0.000 description 1
- DXRVYZGVVFZCFP-UHFFFAOYSA-N 2,4-dibromo-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C=C1Br DXRVYZGVVFZCFP-UHFFFAOYSA-N 0.000 description 1
- QUIMTLZDMCNYGY-UHFFFAOYSA-N 2,4-dichloro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1Cl QUIMTLZDMCNYGY-UHFFFAOYSA-N 0.000 description 1
- GHUPTTDFHNSDCC-UHFFFAOYSA-N 2,6-dimethyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC(C)=C2NC(=O)C2=C1SC(C)=C2 GHUPTTDFHNSDCC-UHFFFAOYSA-N 0.000 description 1
- PSCYLRDKWFNTIO-UHFFFAOYSA-N 2,8-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(C)C=C2OC2=C1C=C(C)S2 PSCYLRDKWFNTIO-UHFFFAOYSA-N 0.000 description 1
- JXKKFWTURRXZBN-UHFFFAOYSA-N 2,9-dimethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC(C)=C2OC2=C1C=C(C)S2 JXKKFWTURRXZBN-UHFFFAOYSA-N 0.000 description 1
- RCUISCLKUPFARM-UHFFFAOYSA-N 2-(4,5-difluoro-2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound [O-][N+](=O)C1=CC(F)=C(F)C=C1NC1=C(C#N)C2=CC=CC=C2S1 RCUISCLKUPFARM-UHFFFAOYSA-N 0.000 description 1
- VLZVIIYRNMWPSN-UHFFFAOYSA-N 2-Amino-4-nitrophenol Chemical compound NC1=CC([N+]([O-])=O)=CC=C1O VLZVIIYRNMWPSN-UHFFFAOYSA-N 0.000 description 1
- DOPJTDJKZNWLRB-UHFFFAOYSA-N 2-Amino-5-nitrophenol Chemical compound NC1=CC=C([N+]([O-])=O)C=C1O DOPJTDJKZNWLRB-UHFFFAOYSA-N 0.000 description 1
- KUANQABNAAGHGX-UHFFFAOYSA-N 2-acetyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=O)C)=C2 KUANQABNAAGHGX-UHFFFAOYSA-N 0.000 description 1
- FEDLEBCVFZMHBP-UHFFFAOYSA-N 2-amino-3-methylphenol Chemical compound CC1=CC=CC(O)=C1N FEDLEBCVFZMHBP-UHFFFAOYSA-N 0.000 description 1
- SWFNPENEBHAHEB-UHFFFAOYSA-N 2-amino-4-chlorophenol Chemical compound NC1=CC(Cl)=CC=C1O SWFNPENEBHAHEB-UHFFFAOYSA-N 0.000 description 1
- ULDFRPKVIZMKJG-UHFFFAOYSA-N 2-amino-4-fluorophenol Chemical compound NC1=CC(F)=CC=C1O ULDFRPKVIZMKJG-UHFFFAOYSA-N 0.000 description 1
- HERKXOIBIXCBST-UHFFFAOYSA-N 2-amino-4-methyl-1-benzothiophene-3-carbonitrile Chemical compound CC1=CC=CC2=C1C(C#N)=C(N)S2 HERKXOIBIXCBST-UHFFFAOYSA-N 0.000 description 1
- FZCQMIRJCGWWCL-UHFFFAOYSA-N 2-amino-5-chlorophenol Chemical compound NC1=CC=C(Cl)C=C1O FZCQMIRJCGWWCL-UHFFFAOYSA-N 0.000 description 1
- UPEWNVDJDYMWIV-UHFFFAOYSA-N 2-amino-5-fluorobenzenethiol Chemical compound NC1=CC=C(F)C=C1S UPEWNVDJDYMWIV-UHFFFAOYSA-N 0.000 description 1
- AOWNYDDZDLTCGB-UHFFFAOYSA-N 2-amino-5-methoxyphenol Chemical compound COC1=CC=C(N)C(O)=C1 AOWNYDDZDLTCGB-UHFFFAOYSA-N 0.000 description 1
- VUMZNLOQJGKGNE-UHFFFAOYSA-N 2-amino-5-methylbenzenethiol Chemical compound CC1=CC=C(N)C(S)=C1 VUMZNLOQJGKGNE-UHFFFAOYSA-N 0.000 description 1
- QQPPEPAITIGSDB-UHFFFAOYSA-N 2-amino-6-chloro-1-benzothiophene-3-carbonitrile Chemical compound ClC1=CC=C2C(C#N)=C(N)SC2=C1 QQPPEPAITIGSDB-UHFFFAOYSA-N 0.000 description 1
- LYALITHCWUWRNL-UHFFFAOYSA-N 2-amino-6-methoxy-1-benzothiophene-3-carbonitrile Chemical compound COC1=CC=C2C(C#N)=C(N)SC2=C1 LYALITHCWUWRNL-UHFFFAOYSA-N 0.000 description 1
- GWXIGCZEXDVFDN-UHFFFAOYSA-N 2-amino-6-methoxyphenol;hydrochloride Chemical compound Cl.COC1=CC=CC(N)=C1O GWXIGCZEXDVFDN-UHFFFAOYSA-N 0.000 description 1
- ALQKEYVDQYGZDN-UHFFFAOYSA-N 2-amino-6-methylphenol Chemical compound CC1=CC=CC(N)=C1O ALQKEYVDQYGZDN-UHFFFAOYSA-N 0.000 description 1
- YKUIUGKUVZIJML-UHFFFAOYSA-N 2-amino-7-methyl-1-benzothiophene-3-carbonitrile Chemical compound CC1=CC=CC2=C1SC(N)=C2C#N YKUIUGKUVZIJML-UHFFFAOYSA-N 0.000 description 1
- ZMXYNJXDULEQCK-UHFFFAOYSA-N 2-amino-p-cresol Chemical compound CC1=CC=C(O)C(N)=C1 ZMXYNJXDULEQCK-UHFFFAOYSA-N 0.000 description 1
- VPLITVQPROCSGC-UHFFFAOYSA-N 2-bromo-4,5-dimethylthiophene-3-carboxylic acid Chemical compound CC=1SC(Br)=C(C(O)=O)C=1C VPLITVQPROCSGC-UHFFFAOYSA-N 0.000 description 1
- JVDQJOISQUFSOE-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-3-methoxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound COC1=CC=CC(NC(=O)C2=C(SC(C)=C2)Br)=C1O JVDQJOISQUFSOE-UHFFFAOYSA-N 0.000 description 1
- PIGRXBLQJMBRND-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC(C)=CC=2)O)=C1Br PIGRXBLQJMBRND-UHFFFAOYSA-N 0.000 description 1
- RNASWPJHRNFGJQ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-4-methylphenyl)thiophene-3-carboxamide Chemical compound OC1=CC(C)=CC=C1NC(=O)C1=C(Br)SC=C1 RNASWPJHRNFGJQ-UHFFFAOYSA-N 0.000 description 1
- WFKFWNKQAAJRKV-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-5-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=C(C)C=2)O)=C1Br WFKFWNKQAAJRKV-UHFFFAOYSA-N 0.000 description 1
- BFSADIBQUPNNDZ-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-5-methylphenyl)thiophene-3-carboxamide Chemical compound CC1=CC=C(O)C(NC(=O)C2=C(SC=C2)Br)=C1 BFSADIBQUPNNDZ-UHFFFAOYSA-N 0.000 description 1
- UISZREWDZBZFRY-UHFFFAOYSA-N 2-bromo-n-(2-hydroxy-6-methylphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=CC=2C)O)=C1Br UISZREWDZBZFRY-UHFFFAOYSA-N 0.000 description 1
- QDUDWDNKLUXTKI-UHFFFAOYSA-N 2-bromo-n-(4-fluoro-2-sulfanylphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound SC1=CC(F)=CC=C1NC(=O)C1=C(Br)SC2=C1CCCC2 QDUDWDNKLUXTKI-UHFFFAOYSA-N 0.000 description 1
- WYHJTBNPHPQWAA-UHFFFAOYSA-N 2-bromo-n-(5-chloro-2-hydroxyphenyl)thiophene-3-carboxamide Chemical compound OC1=CC=C(Cl)C=C1NC(=O)C1=C(Br)SC=C1 WYHJTBNPHPQWAA-UHFFFAOYSA-N 0.000 description 1
- ZNAHUHLSZGPUCY-UHFFFAOYSA-N 2-bromo-n-(5-fluoro-2-hydroxyphenyl)-5-methylthiophene-3-carboxamide Chemical compound S1C(C)=CC(C(=O)NC=2C(=CC=C(F)C=2)O)=C1Br ZNAHUHLSZGPUCY-UHFFFAOYSA-N 0.000 description 1
- DLOZETMETORDEF-UHFFFAOYSA-N 2-bromo-n-(5-fluoro-2-hydroxyphenyl)thiophene-3-carboxamide Chemical compound OC1=CC=C(F)C=C1NC(=O)C1=C(Br)SC=C1 DLOZETMETORDEF-UHFFFAOYSA-N 0.000 description 1
- RVSXMPCELBYUSF-UHFFFAOYSA-N 2-bromothiophene-3-carboxylic acid Chemical compound OC(=O)C=1C=CSC=1Br RVSXMPCELBYUSF-UHFFFAOYSA-N 0.000 description 1
- BEGNSDBJAQDAOD-UHFFFAOYSA-N 2-butanoyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=O)CCC)=C2 BEGNSDBJAQDAOD-UHFFFAOYSA-N 0.000 description 1
- MGXFNZZLZMCAHA-UHFFFAOYSA-N 2-ethyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound S1C(CC)=CC2=C1OC1=CC=CC=C1N=C2N1CCN(C)CC1 MGXFNZZLZMCAHA-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- NJJYJPMYBSLRGI-UHFFFAOYSA-N 2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=C1C=C(C)S2 NJJYJPMYBSLRGI-UHFFFAOYSA-N 0.000 description 1
- RRKWYOVRNXDVRH-UHFFFAOYSA-N 2-phenyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound C=1C=2C(=O)NC3=CC=CC=C3OC=2SC=1C1=CC=CC=C1 RRKWYOVRNXDVRH-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- GSAWTEZCBAXVCA-UHFFFAOYSA-N 2-prop-1-en-2-yl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=C)C)=C2 GSAWTEZCBAXVCA-UHFFFAOYSA-N 0.000 description 1
- MHECHTRMDMIWQH-UHFFFAOYSA-N 2-propanoyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC=CC=C2NC(=O)C2=C1SC(C(=O)CC)=C2 MHECHTRMDMIWQH-UHFFFAOYSA-N 0.000 description 1
- CEPJSVJGXDFRRF-UHFFFAOYSA-N 3,8-difluoro-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine Chemical compound NC1=NC2=CC=C(F)C=C2NC2=C1C1=CC=C(F)C=C1S2 CEPJSVJGXDFRRF-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- CQSDGAYUGYEAPC-UHFFFAOYSA-N 3-methyl-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C1=CC=C(C)C=C1S2 CQSDGAYUGYEAPC-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- BHDICENSHJPKPK-UHFFFAOYSA-N 4-methyl-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine Chemical compound N1C2=CC=CC=C2N=C(N)C2=C1SC1=C2C=CC=C1C BHDICENSHJPKPK-UHFFFAOYSA-N 0.000 description 1
- DDMJYHKSLSZRPF-UHFFFAOYSA-N 5-bromo-n-(2-hydroxyphenyl)thiophene-3-carboxamide Chemical compound OC1=CC=CC=C1NC(=O)C1=CSC(Br)=C1 DDMJYHKSLSZRPF-UHFFFAOYSA-N 0.000 description 1
- LZNUPQPAULVPPX-UHFFFAOYSA-N 5h-1,5-benzoxazepin-4-one Chemical compound O1C=CC(=O)NC2=CC=CC=C21 LZNUPQPAULVPPX-UHFFFAOYSA-N 0.000 description 1
- XBWAZCLHZCFCGK-UHFFFAOYSA-N 7-chloro-1-methyl-5-phenyl-3,4-dihydro-2h-1,4-benzodiazepin-1-ium;chloride Chemical compound [Cl-].C12=CC(Cl)=CC=C2[NH+](C)CCN=C1C1=CC=CC=C1 XBWAZCLHZCFCGK-UHFFFAOYSA-N 0.000 description 1
- FQKDKKBWCDEXLT-UHFFFAOYSA-N 7-methyl-2-(2-nitroanilino)-1-benzothiophene-3-carbonitrile Chemical compound S1C=2C(C)=CC=CC=2C(C#N)=C1NC1=CC=CC=C1[N+]([O-])=O FQKDKKBWCDEXLT-UHFFFAOYSA-N 0.000 description 1
- DFGBJIQJTUWFCP-UHFFFAOYSA-N 8,9-difluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC(F)=C(F)C=C2NC2=C1C1=CC=CC=C1S2 DFGBJIQJTUWFCP-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- AHNHWPMRIUHTRI-UHFFFAOYSA-N 8-chloro-2-methyl-4-(4-methylpiperazin-1-yl)thieno[2,3-b][1,5]benzoxazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(Cl)C=C2OC2=C1C=C(C)S2 AHNHWPMRIUHTRI-UHFFFAOYSA-N 0.000 description 1
- XMCSIFKEDRSJGE-UHFFFAOYSA-N 8-fluoro-2,3,4,11-tetrahydro-1h-[1]benzothiolo[2,3-b][1,5]benzothiazepin-12-one Chemical compound S1C2=CC(F)=CC=C2NC(=O)C2=C1SC1=C2CCCC1 XMCSIFKEDRSJGE-UHFFFAOYSA-N 0.000 description 1
- YJFJIYZTSWKSNN-UHFFFAOYSA-N 8-fluoro-2-methyl-12-(4-methylpiperazin-1-yl)-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=C(F)C=C2NC2=C1C1=CC(C)=CC=C1S2 YJFJIYZTSWKSNN-UHFFFAOYSA-N 0.000 description 1
- IJWNZHWQGFOHGA-UHFFFAOYSA-N 8-fluoro-2-methyl-5h-thieno[2,3-b][1,5]benzoxazepin-4-one Chemical compound O1C2=CC(F)=CC=C2NC(=O)C2=C1SC(C)=C2 IJWNZHWQGFOHGA-UHFFFAOYSA-N 0.000 description 1
- IXYDZOOZNRUTMZ-UHFFFAOYSA-N 8-fluoro-3-methoxy-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine Chemical compound N1C2=CC(F)=CC=C2N=C(N)C2=C1SC1=CC(OC)=CC=C12 IXYDZOOZNRUTMZ-UHFFFAOYSA-N 0.000 description 1
- GCPSYBWZEVURIS-UHFFFAOYSA-N 8-fluoro-6h-[1]benzothiolo[2,3-b][1,5]benzodiazepin-12-amine Chemical compound NC1=NC2=CC=C(F)C=C2NC2=C1C1=CC=CC=C1S2 GCPSYBWZEVURIS-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010001540 Akathisia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012239 Delusion Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000014094 Dystonic disease Diseases 0.000 description 1
- 229920006358 Fluon Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- HOKKHZGPKSLGJE-UHFFFAOYSA-N N-methyl-D-aspartic acid Natural products CNC(C(O)=O)CC(O)=O HOKKHZGPKSLGJE-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010041243 Social avoidant behaviour Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- NFGODEMQGQNUKK-UHFFFAOYSA-M [6-(diethylamino)-9-(2-octadecoxycarbonylphenyl)xanthen-3-ylidene]-diethylazanium;chloride Chemical group [Cl-].CCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C1=C2C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C21 NFGODEMQGQNUKK-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 208000018300 basal ganglia disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- RVSGRNKUJJUAPV-UHFFFAOYSA-N benzo[d][1,2]benzoxazepine Chemical compound O1N=CC2=CC=CC=C2C2=CC=CC=C12 RVSGRNKUJJUAPV-UHFFFAOYSA-N 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical compound [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- FIMJSWFMQJGVAM-UHFFFAOYSA-N chloroform;hydrate Chemical compound O.ClC(Cl)Cl FIMJSWFMQJGVAM-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 231100000868 delusion Toxicity 0.000 description 1
- 150000008509 dibenzothiazepines Chemical class 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- FOBPTJZYDGNHLR-UHFFFAOYSA-N diphosphorus Chemical compound P#P FOBPTJZYDGNHLR-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000010118 dystonia Diseases 0.000 description 1
- 238000001362 electron spin resonance spectrum Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- IZMTYJKUUQRHTQ-UHFFFAOYSA-N ethyl 2-(2,3-dichloro-6-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=C(Cl)C(Cl)=CC=C1[N+]([O-])=O IZMTYJKUUQRHTQ-UHFFFAOYSA-N 0.000 description 1
- OEZYIDWJJDWNPC-UHFFFAOYSA-N ethyl 2-(2-amino-4-bromoanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(Br)C=C1N OEZYIDWJJDWNPC-UHFFFAOYSA-N 0.000 description 1
- CUWFNNQAXFZUJN-UHFFFAOYSA-N ethyl 2-(2-amino-4-chloroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(Cl)C=C1N CUWFNNQAXFZUJN-UHFFFAOYSA-N 0.000 description 1
- BWYAWEWVMSPYGP-UHFFFAOYSA-N ethyl 2-(2-amino-5-fluoroanilino)-6-methoxy-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(OC)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1N BWYAWEWVMSPYGP-UHFFFAOYSA-N 0.000 description 1
- LGHMKSYKHRFSSO-UHFFFAOYSA-N ethyl 2-(2-amino-5-fluoroanilino)-6-methyl-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(C)=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1N LGHMKSYKHRFSSO-UHFFFAOYSA-N 0.000 description 1
- XXPZIBKFEFHFPQ-UHFFFAOYSA-N ethyl 2-(2-amino-n-methylanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1N(C)C1=CC=CC=C1N XXPZIBKFEFHFPQ-UHFFFAOYSA-N 0.000 description 1
- KSVNPKXAMCDFOU-UHFFFAOYSA-N ethyl 2-(2-aminoanilino)-6-methoxy-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC(OC)=CC=C2C(C(=O)OCC)=C1NC1=CC=CC=C1N KSVNPKXAMCDFOU-UHFFFAOYSA-N 0.000 description 1
- FFWVCSOPLROOET-UHFFFAOYSA-N ethyl 2-(4,5-dichloro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(Cl)=C(Cl)C=C1[N+]([O-])=O FFWVCSOPLROOET-UHFFFAOYSA-N 0.000 description 1
- QUXSUQCDMSEBGT-UHFFFAOYSA-N ethyl 2-(4-methyl-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(C)C=C1[N+]([O-])=O QUXSUQCDMSEBGT-UHFFFAOYSA-N 0.000 description 1
- OPHNIDQUUBCEDY-UHFFFAOYSA-N ethyl 2-(5-fluoro-2-nitroanilino)-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC(F)=CC=C1[N+]([O-])=O OPHNIDQUUBCEDY-UHFFFAOYSA-N 0.000 description 1
- FPNGVIKBXQOXRF-UHFFFAOYSA-N ethyl 2-[2-nitro-4-(trifluoromethyl)anilino]-1-benzothiophene-3-carboxylate Chemical compound S1C2=CC=CC=C2C(C(=O)OCC)=C1NC1=CC=C(C(F)(F)F)C=C1[N+]([O-])=O FPNGVIKBXQOXRF-UHFFFAOYSA-N 0.000 description 1
- OAJABPBNNASBFC-UHFFFAOYSA-N ethyl 2-amino-6-bromo-1-benzothiophene-3-carboxylate Chemical compound BrC1=CC=C2C(C(=O)OCC)=C(N)SC2=C1 OAJABPBNNASBFC-UHFFFAOYSA-N 0.000 description 1
- KRHUTJDRKGFWQD-UHFFFAOYSA-N ethyl 2-bromo-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate Chemical compound C1CCCC2=C1SC(Br)=C2C(=O)OCC KRHUTJDRKGFWQD-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- KIDXHMTZGRXJHE-UHFFFAOYSA-N ethyl acetate;methanol;2-propan-2-yloxypropane Chemical compound OC.CCOC(C)=O.CC(C)OC(C)C KIDXHMTZGRXJHE-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- MOTRZVVGCFFABN-UHFFFAOYSA-N hexane;2-propan-2-yloxypropane Chemical compound CCCCCC.CC(C)OC(C)C MOTRZVVGCFFABN-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- YXFSJHIKSHCRDI-UHFFFAOYSA-N iodomethane;magnesium Chemical compound [Mg].IC YXFSJHIKSHCRDI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N methyl cyclohexan-4-ol Natural products CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- 239000012022 methylating agents Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 description 1
- UNBDDZDKBWPHAX-UHFFFAOYSA-N n,n-di(propan-2-yl)formamide Chemical compound CC(C)N(C=O)C(C)C UNBDDZDKBWPHAX-UHFFFAOYSA-N 0.000 description 1
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
- JIKUXBYRTXDNIY-UHFFFAOYSA-N n-methyl-n-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000000802 nitrating effect Effects 0.000 description 1
- JCZMXVGQBBATMY-UHFFFAOYSA-N nitro acetate Chemical compound CC(=O)O[N+]([O-])=O JCZMXVGQBBATMY-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 229950010883 phencyclidine Drugs 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- VIKLRYNBOIWKMX-UHFFFAOYSA-N pyrido[2,3-i][1,2]benzoxazepine Chemical compound O1N=CC=CC2=CC=C(N=CC=C3)C3=C12 VIKLRYNBOIWKMX-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- ZTHJULTYCAQOIJ-WXXKFALUSA-N quetiapine fumarate Chemical compound [H+].[H+].[O-]C(=O)\C=C\C([O-])=O.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 ZTHJULTYCAQOIJ-WXXKFALUSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 108091006082 receptor inhibitors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 229940035004 seroquel Drugs 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- DGQOCLATAPFASR-UHFFFAOYSA-N tetrahydroxy-1,4-benzoquinone Chemical compound OC1=C(O)C(=O)C(O)=C(O)C1=O DGQOCLATAPFASR-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 1
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Substances O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- HTSABYAWKQAHBT-UHFFFAOYSA-N trans 3-methylcyclohexanol Natural products CC1CCCC(O)C1 HTSABYAWKQAHBT-UHFFFAOYSA-N 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- MDCWDBMBZLORER-UHFFFAOYSA-N triphenyl borate Chemical compound C=1C=CC=CC=1OB(OC=1C=CC=CC=1)OC1=CC=CC=C1 MDCWDBMBZLORER-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23670097 | 1997-09-02 | ||
| JP27777197 | 1997-10-09 | ||
| JP16572598 | 1998-06-12 | ||
| PCT/JP1998/003915 WO1999011647A1 (en) | 1997-09-02 | 1998-08-31 | Fused thiophene compounds and medicinal use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ503484A true NZ503484A (en) | 2001-10-26 |
Family
ID=27322564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ503484A NZ503484A (en) | 1997-09-02 | 1998-08-31 | Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives |
Country Status (16)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6590083B1 (en) | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| US6399582B1 (en) | 1999-04-16 | 2002-06-04 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| US6751036B2 (en) * | 2000-08-04 | 2004-06-15 | Seagate Technology Llc | Tuning track density for data storage device |
| US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
| EP2363396A1 (en) * | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| ES2285227T3 (es) | 2002-08-05 | 2007-11-16 | Eli Lilly And Company | Arilbenzodiazepinas sustituidas con piperazina. |
| DE60332482D1 (de) | 2002-12-10 | 2010-06-17 | Virochem Pharma Inc | Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen |
| US20040236181A1 (en) * | 2003-04-01 | 2004-11-25 | Olympus Corporation | In-body information acquiring apparatus and power-supply circuit |
| CA2536107A1 (en) * | 2003-09-09 | 2005-03-24 | Eli Lilly And Company | Substituted piperazines of azepines, oxazepines, and thiazepines |
| RU2248205C1 (ru) * | 2003-09-18 | 2005-03-20 | Открытое акционерное общество "Щелковский витаминный завод" | Лекарственное средство в виде желатиновой капсулы |
| EP1713486A4 (en) * | 2003-12-02 | 2009-04-29 | Sheldon Leslie James | COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY |
| WO2005063771A1 (en) * | 2003-12-22 | 2005-07-14 | Teva Pharmaceutical Industries Ltd | Methods of preparing olanzapine |
| US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
| SG176488A1 (en) * | 2006-11-15 | 2011-12-29 | Virochem Pharma Inc | Thiophene analogues for the treatment or prevention of flavivirus infections |
| PL395468A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego |
| JP6551671B2 (ja) * | 2015-08-11 | 2019-07-31 | 国立大学法人 熊本大学 | アルツハイマー治療薬 |
| US12365696B2 (en) | 2019-05-10 | 2025-07-22 | Dana-Farber Cancer Institute, Inc. | Small-molecule focal adhesion kinase (FAK) inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140242B (nl) | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
| CH468400A (de) | 1965-12-23 | 1969-02-15 | Sandoz Ag | Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen |
| US3683084A (en) | 1969-02-06 | 1972-08-08 | Jean Schmutz | Basically substituted heterocycles as anti-emetics |
| US3726977A (en) | 1969-02-06 | 1973-04-10 | Sandoz Ag | 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION |
| US3962248A (en) * | 1972-04-04 | 1976-06-08 | Sandoz, Inc. | Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines |
| SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
| US4115568A (en) | 1974-11-26 | 1978-09-19 | Lilly Industries Limited | Thieno[3,2-b]-[1,5]benzodiazepines |
| US4172831A (en) | 1974-11-26 | 1979-10-30 | Lilly Industries Limited | Thieno-benzodiazepines |
| GB1533236A (en) * | 1975-11-24 | 1978-11-22 | Lilly Industries Ltd | Thieno(1,5)benzodiazepine intermediates |
| US4157444A (en) | 1978-03-13 | 1979-06-05 | American Cyanamid Company | 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines |
| GB9009229D0 (en) | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5538965A (en) | 1993-12-23 | 1996-07-23 | Allelix Biopharmaceuticals Inc. | Dopamine receptor ligands |
| US5602121A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Alkyl-substituted compounds having dopamine receptor affinity |
| US5700445A (en) | 1994-12-12 | 1997-12-23 | Allelix Biopharmaceuticals, Inc. | N-methyl piperazine compounds having dopamine receptor affinity |
| US5602124A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
| US5576314A (en) | 1994-12-12 | 1996-11-19 | Allelix Biopharmaceuticals Inc. | Bicyclic nonane and decane compounds having dopamine receptor affinity |
| US5602120A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Benzyl-substituted compounds having dopamine receptor affinity |
| US5561127A (en) | 1994-12-19 | 1996-10-01 | Allelix Biopharmaceuticals, Inc. | Muscarinic receptor ligands |
-
1998
- 1998-08-31 AU AU88890/98A patent/AU739385B2/en not_active Ceased
- 1998-08-31 RU RU2000108433/04A patent/RU2197491C2/ru not_active IP Right Cessation
- 1998-08-31 WO PCT/JP1998/003915 patent/WO1999011647A1/ja not_active Ceased
- 1998-08-31 JP JP51595799A patent/JP3156933B2/ja not_active Expired - Fee Related
- 1998-08-31 DE DE69816102T patent/DE69816102D1/de not_active Expired - Lifetime
- 1998-08-31 CN CN98808681A patent/CN1268949A/zh active Pending
- 1998-08-31 IL IL13481298A patent/IL134812A0/xx unknown
- 1998-08-31 CA CA002302409A patent/CA2302409A1/en not_active Abandoned
- 1998-08-31 US US09/341,317 patent/US6271225B1/en not_active Expired - Lifetime
- 1998-08-31 AT AT98940666T patent/ATE244245T1/de not_active IP Right Cessation
- 1998-08-31 HU HU0003718A patent/HUP0003718A3/hu unknown
- 1998-08-31 KR KR1020007000556A patent/KR20010021989A/ko not_active Withdrawn
- 1998-08-31 NZ NZ503484A patent/NZ503484A/en unknown
- 1998-08-31 EP EP98940666A patent/EP1016664B1/en not_active Expired - Lifetime
-
1999
- 1999-07-08 BR BR9814042-6A patent/BR9814042A/pt not_active IP Right Cessation
-
2000
- 2000-03-01 NO NO20001049A patent/NO20001049L/no unknown
- 2000-09-22 JP JP2000289527A patent/JP4354106B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-19 US US09/837,424 patent/US6455521B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6271225B1 (en) | 2001-08-07 |
| DE69816102D1 (de) | 2003-08-07 |
| ATE244245T1 (de) | 2003-07-15 |
| IL134812A0 (en) | 2001-04-30 |
| NO20001049L (no) | 2000-04-03 |
| HUP0003718A3 (en) | 2002-11-28 |
| NO20001049D0 (no) | 2000-03-01 |
| JP3156933B2 (ja) | 2001-04-16 |
| KR20010021989A (ko) | 2001-03-15 |
| EP1016664A1 (en) | 2000-07-05 |
| HUP0003718A2 (hu) | 2001-09-28 |
| AU739385B2 (en) | 2001-10-11 |
| US20020042411A1 (en) | 2002-04-11 |
| EP1016664B1 (en) | 2003-07-02 |
| CN1268949A (zh) | 2000-10-04 |
| CA2302409A1 (en) | 1999-03-11 |
| WO1999011647A1 (en) | 1999-03-11 |
| RU2197491C2 (ru) | 2003-01-27 |
| JP2001072684A (ja) | 2001-03-21 |
| AU8889098A (en) | 1999-03-22 |
| US6455521B1 (en) | 2002-09-24 |
| EP1016664A4 (en) | 2001-01-24 |
| BR9814042A (pt) | 2000-10-03 |
| JP4354106B2 (ja) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6271225B1 (en) | Fused thiophene compounds and medicinal use thereof | |
| AU2005315914B2 (en) | Bi- and tricyclic substituted phenyl methanones as glycine transporter I (GlyT-1) inhibitors for the treatment of Alzheimer's disease | |
| JPWO1999011647A1 (ja) | 縮合チオフェン化合物およびその医薬用途 | |
| US20050171101A1 (en) | Phenanthridinones as parp inhibitors | |
| US20070010537A1 (en) | Fused pyramidine derivative and use thereof | |
| JPH09291034A (ja) | 縮合ピリジン化合物およびその医薬としての用途 | |
| US20100190772A1 (en) | Substituted Azepine Derivatives As Serotonin Receptor Modulators | |
| SI9400091A (en) | Substituted pyrrolo(2,3-b)pyridine derivatives | |
| CZ194994A3 (en) | Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| CS9101168A2 (en) | Pharmaceutical mixtures and method of their active substance production | |
| EP0409435A1 (en) | Heteroaryl piperazine antipsychotic agents | |
| CN101679272B (zh) | 作为腺苷a3受体配体的三唑并[1,5-a]喹啉类 | |
| Hussenether et al. | Clozapine derived 2, 3-dihydro-1H-1, 4-and 1, 5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing | |
| WO1997003986A1 (en) | Fused triazole compounds | |
| CS236753B2 (en) | Processing of thieno (1,5) benzodiazepine derivatives | |
| AU2013394970B2 (en) | Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use thereof | |
| US4172831A (en) | Thieno-benzodiazepines | |
| JP2001515892A (ja) | ベンゾキサジン−及びベンゾチアジン−誘導体、ならびにそれらの医薬への応用 | |
| NZ540768A (en) | Benzamide derivatives as oxytocin agonists and vasopressin antagonists | |
| KR20010022658A (ko) | 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도 | |
| HK1029340A (en) | Fused thiophene compounds and medicinal use thereof | |
| JP2005097276A (ja) | 縮合ピリミジン誘導体およびその用途 | |
| KR0145181B1 (ko) | 신규 벤조 [1,8] 나프티리딘 유도체 및 그의 제법 | |
| MXPA00002221A (en) | Fused thiophene compounds and medicinal use thereof | |
| CZ2000757A3 (cs) | Kondenzované thiofenové sloučeniny a jejich farmaceutické použití |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |